CID 146277756

Tibremciclib

Structural Information

Molecular Formula
C28H32F2N8
SMILES
CCN1CCN(CC1)CC2=CN=C(C=C2)NC3=NC=C(C(=N3)C4=CC5=C(C(=C4)F)N=C6N5[C@@H](CCC6)C)F
InChI
InChI=1S/C28H32F2N8/c1-3-36-9-11-37(12-10-36)17-19-7-8-24(31-15-19)33-28-32-16-22(30)26(35-28)20-13-21(29)27-23(14-20)38-18(2)5-4-6-25(38)34-27/h7-8,13-16,18H,3-6,9-12,17H2,1-2H3,(H,31,32,33,35)/t18-/m1/s1
InChIKey
XOJPAVACYRFOBK-GOSISDBHSA-N
Compound name
N-[5-[(4-ethylpiperazin-1-yl)methyl]pyridin-2-yl]-5-fluoro-4-[(1R)-6-fluoro-1-methyl-1,2,3,4-tetrahydropyrido[1,2-a]benzimidazol-8-yl]pyrimidin-2-amine
Related CIDs

2D Structure

compound 2d structure
2
Annotation Hits

0
References

13
Patents

518.2718 Da
Monoisotopic Mass

3.9
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 519.27908 234.0
[M+Na]+ 541.26102 241.5
[M-H]- 517.26452 236.3
[M+NH4]+ 536.30562 233.3
[M+K]+ 557.23496 229.1
[M+H-H2O]+ 501.26906 215.8
[M+HCOO]- 563.27000 239.0
[M+CH3COO]- 577.28565 236.8
[M+Na-2H]- 539.24647 230.5
[M]+ 518.27125 228.9
[M]- 518.27235 228.9
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

No literature data available for this compound.

Patent stripe

patents stripe